CEO of FibroGen & Fibrogen, Inc.
A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness
Fibrogen, Inc. is a San Francisco-based company founded in 1993.